Comparison of Promiscuous and Tissue-Targeted AAV Gene Therapy for Systemic Propionic Acidemia Treatment

被引：0
|
作者：
Guenzel, Adam J. [1 ]
Hillestad, Matthew L. [1 ]
Barry, Michael A. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
MOLECULAR THERAPY | 2014年 / 22卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
360
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 50 条
  • [31] Liver directed gene therapy using AAV9 to treat a new murine model of propionic acidemia caused by Pccb deficiency
    Chandler, R. J.
    Hubbard, B. T.
    Venditti, V. P.
    HUMAN GENE THERAPY, 2018, 29 (12) : A124 - A124
  • [32] Genotoxicity following AAV gene therapy for Methylmalonic Acidemia (MMA) in mice
    Chandler, R. J.
    Ashok, A. A.
    Varshney, G. K.
    LaFave, M. C.
    Wu, W.
    Elkahloun, A. G.
    Burgess, S. M.
    Venditti, C. P.
    HUMAN GENE THERAPY, 2013, 24 (12) : A149 - A149
  • [33] Gene therapy for organic acidemias: Lessons learned from methylmalonic and propionic acidemia
    Chandler, Randy J.
    Venditti, Charles P.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2024, 47 (01) : 63 - 79
  • [34] Systemic corticosteroids and mucosal-associated lymphoid tissue-targeted therapy in immunoglobulin A nephropathy: insight from the NEFIGAN study
    Coppo, Rosanna
    Mariat, Christophe
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (08) : 1291 - 1294
  • [35] Systemic AAV9 Gene Therapy for Propionyl-CoA Carboxylase, Alpha Subunit (AAV9-hPCCA) in a Neonatal Lethal Model of Propionic Acidemia: Dose Finding, Biodistribution, and Long-Term Safety
    Li, Lina
    Choi, Eun-Young
    Wagner, Erik
    Wang, Amy
    Xu, Xin
    Chandler, Randy J.
    Venditti, Charles P.
    MOLECULAR THERAPY, 2023, 31 (04) : 593 - 593
  • [36] Drug Insight: breast cancer prevention and tissue-targeted hormone replacement therapy
    Labrie, Fernand
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (08): : 584 - 593
  • [37] Systemic AAV9 Human Propionyl-CoA Carboxylase, Alpha Subunit (AAV9-hPCCA) Gene Therapy Provides Direct and Sustained Therapeutic Benefits in the Treatment of Propionic Acidemia: From Animal Model to Orphan Drug Designation (ODD)
    Li, Lina
    Choi, Eun-Young
    Smith, Stephanie
    Wagner, Erik
    Chen, Catherine
    Xu, Xin
    Ottinger, Elizabeth
    Brooks, Philip J.
    Chandler, Randy J.
    Venditti, Charles P.
    MOLECULAR THERAPY, 2022, 30 (04) : 473 - 473
  • [38] Drug Insight: breast cancer prevention and tissue-targeted hormone replacement therapy
    Fernand Labrie
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 584 - 593
  • [39] Systemic AAV vectors for widespread and targeted gene delivery in rodents
    Rosemary C. Challis
    Sripriya Ravindra Kumar
    Ken Y. Chan
    Collin Challis
    Keith Beadle
    Min J. Jang
    Hyun Min Kim
    Pradeep S. Rajendran
    John D. Tompkins
    Kalyanam Shivkumar
    Benjamin E. Deverman
    Viviana Gradinaru
    Nature Protocols, 2019, 14 : 379 - 414
  • [40] Systemic AAV vectors for widespread and targeted gene delivery in rodents
    Challis, Rosemary C.
    Kumar, Sripriya Ravindra
    Chan, Ken Y.
    Challis, Collin
    Beadle, Keith
    Jang, Min J.
    Kim, Hyun Min
    Rajendran, Pradeep S.
    Tompkins, John D.
    Shivkumar, Kalyanam
    Deverman, Benjamin E.
    Gradinaru, Viviana
    NATURE PROTOCOLS, 2019, 14 (02) : 379 - 414
12345